Ketamine and learning in eating disorders
Treatments studied
Part of Mental health clinical trials.
This study tests whether a single dose of ketamine can help people with anorexia nervosa learn new ways of thinking about food and body image during recovery. You may be eligible if you are a teenager or young adult currently hospitalized for malnutrition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 16 and 26 years old
- You have anorexia or atypical anorexia and are in the hospital for malnutrition
- Your psychiatric medications have been stable for at least one month
- You agree to use effective birth control for two weeks after receiving ketamine (if applicable)
- You have a regular doctor or therapist managing your care outside the hospital
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a therapeutic ketogenic diet (a very low-carb, high-fat eating plan) can help people with anorexia nervosa, including those who have recently recovered their weight and those who are still underweight. The diet may help improve brain function and reduce eating disorder symptoms.
This study tests if intravenous ketamine can help people with treatment-resistant depression who haven't found relief from at least two other treatments. If you qualify, you'll receive ketamine infusions to see if it improves your mood.
This Phase 2 study tests ketamine for people with major depression that hasn’t improved after at least one antidepressant. It aims to see whether ketamine can reduce depression symptoms during a current depressive episode.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This trial tests if ketamine can help people who have both depression and alcohol use disorder. You must be currently sober, have at least moderate depression, and be admitted to the hospital for addiction treatment.
This study tests whether low-dose ketamine infusions can reduce depressive symptoms in patients staying in the intensive care unit for at least 6 days. Ketamine is a medication that may work differently than standard antidepressants and could provide faster relief.
Hear when a new Anorexia Nervosa trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.